LIPS-A: Lung Injury Prevention Study With Aspirin (NCT01504867) | Clinical Trial Compass
CompletedPhase 2
LIPS-A: Lung Injury Prevention Study With Aspirin
United States400 participantsStarted 2012-01
Plain-language summary
The primary hypothesis was that early aspirin administration will decrease the rate of developing acute lung injury during the first 7 days after presentation to the hospital.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients (age \> 18) admitted to the hospital through the emergency department (ED)
* At high risk of developing acute lung injury (ALI) Lung Injury Prediction Score (LIPS) greater than or equal to 4
Exclusion Criteria:
* Anti-platelet therapy on admission or within 7 days prior to admission
* Presented to outside hospital ED \> 12 hrs before arrival at site's facility
* Inability to obtain consent within 12 hours of hospital presentation
* Admitted for elective surgery
* Acute lung injury prior to randomization
* Receiving mechanical ventilation through a tracheostomy tube prior to current hospital admission (patient who is ventilator dependent)
* Presence of bilateral pulmonary infiltrates on admission if he or she has a history of bilateral pulmonary infiltrates (as evidenced by previous x-rays) that can reasonably explain the current degree of pulmonary infiltrates present.
* Presentation due to pure heart failure and no other known risk factors for ALI.
* Allergy to aspirin or non steroidal anti inflammatory drugs (NSAIDs)
* Bleeding disorder
* Suspected active bleeding or judged to be at high risk for bleeding
* Active peptic ulcer disease (within past 6 months)
* Severe chronic liver disease
* Inability to administer the study drug
* Expected hospital stay \< 48 hours
* Admitted for comfort or hospice care
* Patient, surrogate or physician not committed to full support. (Exception: a patient will not be excluded if he/she would receive al…
What they're measuring
1
Number of Participants Who Developed Acute Respiratory Distress Syndrome (ARDS) Within 7 Days
Timeframe: Within seven days from hospital presentation